Reframing Tariff Liability: Smarter US Market Access for Pharma Supply Chains

Escalating US tariffs on pharmaceuticals and active pharmaceutical ingredients are reshaping how international sponsors and CDMOs think about market access and supply chain design. For many organizations, contract packaging has emerged as a strategic lever — offering a compliant, efficient pathway into the US market without the cost and complexity of full domestic manufacturing buildout.